13 employees
PreComb develops technologies to optimally adapt the therapies to each patient for difficult to treat cancers.
2018
$2.4M
from 4 investors over 4 rounds
PreComb Therapeutics raised $1.3M on October 4, 2022
Investors: LongeVC and Kinled Holding Ltd
PreComb Therapeutics raised $2.4M on April 27, 2021
Investors: Kinled Holding Ltd and High-Tech Gründerfonds